These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 6184410
1. Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen. Carter RH, Drebin JA, Schatten S, Perry LL, Greene MI. J Immunol; 1983 Feb; 130(2):997-1002. PubMed ID: 6184410 [Abstract] [Full Text] [Related]
2. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH, Daynes RA, Hodes RJ. J Immunol; 1986 Feb 15; 136(4):1521-7. PubMed ID: 2418117 [Abstract] [Full Text] [Related]
11. T cell regulation of B cell activation: antigen-specific and antigen-nonspecific suppressor pathways are mediated by distinct T cell subpopulations. Asano Y, Hodes RJ. J Immunol; 1983 Mar 15; 130(3):1061-5. PubMed ID: 6185568 [Abstract] [Full Text] [Related]
12. Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo. Perry LL, Benacerraf B, Greene MI. J Immunol; 1978 Dec 15; 121(6):2144-7. PubMed ID: 82578 [Abstract] [Full Text] [Related]
13. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt-Verhulst AM, Pierres M. J Immunol; 1984 Jun 15; 132(6):2775-82. PubMed ID: 6202760 [Abstract] [Full Text] [Related]
14. Regulatory role of T lymphocytes and NK cells in tumor allograft development. Sobotková E, Nouza K. Neoplasma; 1993 Jun 15; 40(2):75-80. PubMed ID: 8350958 [Abstract] [Full Text] [Related]
15. Establishment of a continuous T cell line capable of suppressing anti-tumor immune responses in vivo. Roberts LK, Spellman CW, Warner NL. J Immunol; 1983 Jul 15; 131(1):514-9. PubMed ID: 6223081 [Abstract] [Full Text] [Related]